Kadcyla Intravenous infusion 100mg, manufactured by Chugai Pharmaceutical, contains Trastuzumab emtansine (genetical recombination). With YJ code 4291426D1026 and standard 100mg bottle, it is an antibody-drug conjugate used for HER2-positive metastatic breast cancer.
Kadcyla Intravenous infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →